Leonteq Securities AG Makes New $735,000 Investment in Humana Inc. $HUM

Leonteq Securities AG bought a new position in Humana Inc. (NYSE:HUM) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 2,868 shares of the insurance provider’s stock, valued at approximately $735,000.

Other hedge funds also recently made changes to their positions in the company. Montag A & Associates Inc. increased its stake in shares of Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after buying an additional 94 shares during the period. CoreCap Advisors LLC increased its stake in shares of Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after buying an additional 37 shares during the period. Rosenberg Matthew Hamilton increased its stake in shares of Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after buying an additional 68 shares during the period. Larson Financial Group LLC increased its stake in shares of Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after buying an additional 81 shares during the period. Finally, Fulcrum Asset Management LLP purchased a new position in shares of Humana in the third quarter worth $42,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, insider Sanjay K. Shetty purchased 810 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The shares were acquired at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the acquisition, the insider directly owned 11,657 shares in the company, valued at approximately $2,158,992.97. The trade was a 7.47% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.20% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages recently commented on HUM. Deutsche Bank Aktiengesellschaft downgraded shares of Humana from a “buy” rating to a “hold” rating in a research note on Wednesday. Royal Bank Of Canada lifted their target price on shares of Humana from $189.00 to $246.00 and gave the stock a “sector perform” rating in a research note on Thursday, April 30th. Seaport Research Partners downgraded shares of Humana to a “neutral” rating in a research note on Wednesday. UBS Group lifted their target price on shares of Humana from $262.00 to $320.00 and gave the stock a “neutral” rating in a research note on Friday. Finally, Cantor Fitzgerald began coverage on shares of Humana in a research note on Wednesday. They issued an “overweight” rating on the stock. Nine research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $263.35.

Humana Stock Performance

NYSE:HUM opened at $307.79 on Friday. The stock has a market cap of $36.95 billion, a P/E ratio of 32.92, a price-to-earnings-growth ratio of 2.82 and a beta of 0.68. The firm’s fifty day simple moving average is $218.13 and its 200 day simple moving average is $227.64. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $315.66. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating the consensus estimate of $9.97 by $0.34. The business had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, research analysts predict that Humana Inc. will post 9.01 EPS for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.2%. Humana’s payout ratio is 37.86%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.